Latest Health News

Minerals 260 Limited has completed its acquisition of the Bullabulling Gold Project, backed by a $220 million capital raise, and is advancing an extensive drilling program that confirms promising gold mineralisation extensions.

Emyria has inked a pivotal agreement with Avive Health to launch its first Empax clinic in Queensland, expanding its innovative mental health treatment network. This move builds on its recent Medibank partnership, advancing accessible, reimbursed care for treatment-resistant conditions.

Resolute Mining reported solid Q2 2025 gold production of 75,962 ounces and maintained its full-year guidance, supported by strategic project acquisitions and steady progress across key West African assets.

Wisr Limited has reported a standout Q4FY25 with loan originations soaring 154% year-on-year, surpassing its full-year guidance and showcasing improved credit quality.

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.

BCI Minerals reports solid progress on its Mardie Salt Operation with 69% construction complete and commissioning of the first crystallisers, advancing towards first salt shipment by late 2026.

Sandfire Resources reported a 12% rise in copper equivalent production for FY25, narrowly missing guidance due to severe weather and power outages, while slashing net debt by $273 million. The company projects further growth in FY26 despite expected cost pressures.

E79 Gold Mines Limited reported a solid cash position of AUD 2.11 million at the end of June 2025, balancing ongoing exploration costs with fresh financing inflows. The quarterly cash flow report reveals how the company is managing its funding amid active gold exploration.

Sandon Capital Investments announces a fully franked 1.4 cent dividend for the September quarter, reflecting robust FY2025 portfolio returns and a healthy dividend yield.

Anatara Lifesciences has received nearly $1 million from the Australian Government’s R&D tax incentive, providing a vital capital injection to advance its Anti-Obesity pre-clinical studies.

Moab Minerals is progressing its Manyoni uranium project with a planned JORC-compliant resource estimate and is nearing completion of a key tenement acquisition, while securing fresh funding to support ongoing exploration.

International Graphite Limited (ASX – IG6) has had its trading suspension lifted following the announcement of a new agreement to develop a graphite processing facility in Europe.